Article
San Francisco - New melanoma staging criteria will be "vitallyimportant" for assigning patients into various risk categories as awider variety of adjuvant therapies become available, according to CharlesM. Balch, M.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.